{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T08:03:23Z","timestamp":1695801803864},"reference-count":176,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T00:00:00Z","timestamp":1247097600000},"content-version":"unspecified","delay-in-days":11208,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychol. Med."],"published-print":{"date-parts":[[1978,11]]},"abstract":"<jats:title>Synopsis<\/jats:title><jats:p>The possibility that pharmacological response might help to refine psychiatric nosology has been the subject of recurrent speculation, but few clear-cut results have been obtained. Only bipolar depressives and several other minor patient subgroups manifest consistent drug responses in association with characteristic psychobiological features. The presence of multiple intervening variables, such as individual differences in drug metabolism, drug-taking behaviour and biological sensitivity to drugs, may mitigate against the reliable identification of clinically distinguishable drugresponding subgroups. Furthermore, the majority of available psychoactive drugs have either multiple or broad spectrum effects inconsistent with hypotheses utilizing the mechanism or site of drug action to argue for a diagnosis-specific biological disorder at such sites.<\/jats:p><jats:p>Nonetheless the successful use of drug-response models in other areas of medicine suggests a rationale for continued exploration in this area, and a number of recent advances make this approach potentially more productive. Pharmacological developments have rendered it possible to assess the biological availability of drugs in potential responders, thus eliminating some of the confounding intervening variables. Further consideration should also be given to the use of drugs with more specific neurochemical effects, even when they themselves are not necessarily therapeutic. The comparison of drug responder and non-responder groups has also been made more meaningful by the availability of more reliable methods of assessing clinical phenomena, more sophisticated diagnostic models and the introduction of other biological measures. Combining several of these approaches may allow the use of one to validate the other.<\/jats:p>","DOI":"10.1017\/s0033291700018870","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T15:53:11Z","timestamp":1247154791000},"page":"667-681","source":"Crossref","is-referenced-by-count":13,"title":["Drug response and psychiatric nosology"],"prefix":"10.1017","volume":"8","author":[{"given":"Robin M.","family":"Murray","sequence":"first","affiliation":[]},{"given":"Dennis L.","family":"Murphy","sequence":"additional","affiliation":[]}],"member":"56","published-online":{"date-parts":[[2009,7,9]]},"reference":[{"key":"S0033291700018870_ref176","first-page":"189","volume-title":"Psychopathology and Psychopharmacology","author":"Zubin","year":"1973"},{"key":"S0033291700018870_ref175","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(77)90011-5"},{"key":"S0033291700018870_ref174","volume-title":"Report of the International Pilot Study of Schizophrenia","volume":"1","year":"1973"},{"key":"S0033291700018870_ref172","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1975.01760270104015"},{"key":"S0033291700018870_ref170","volume-title":"Psychotropic Drug Response","author":"Wittenborn","year":"1969"},{"key":"S0033291700018870_ref169","volume-title":"Measurement and Classification of Psychiatric Symptoms","author":"Wing","year":"1974"},{"key":"S0033291700018870_ref166","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.129.2.125"},{"key":"S0033291700018870_ref165","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770120047004"},{"key":"S0033291700018870_ref163","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-349-03753-7_8"},{"key":"S0033291700018870_ref162","unstructured":"van Kammen D. P. & Murphy D. L. (1979). (In preparation)."},{"key":"S0033291700018870_ref160","unstructured":"U.S. Food and Drug Administration (1976). Federal Register."},{"key":"S0033291700018870_ref156","doi-asserted-by":"publisher","DOI":"10.1016\/0010-440X(70)90014-3"},{"key":"S0033291700018870_ref153","volume-title":"Schedule for Affective Disorder and Schizophrenia","author":"Spitzer","year":"1977"},{"key":"S0033291700018870_ref152","volume-title":"Current Issues in Psychiatric Diagnosis","author":"Spitzer","year":"1978"},{"key":"S0033291700018870_ref147","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770090083008"},{"key":"S0033291700018870_ref145","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700040587"},{"key":"S0033291700018870_ref144","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1176\/ajp.133.12.1409","article-title":"The effect of lithium on impulsive aggressive behaviour in man","volume":"133","author":"Sheard","year":"1976","journal-title":"American Journal of Psychiatry"},{"key":"S0033291700018870_ref143","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.17.4.250"},{"key":"S0033291700018870_ref142","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(68)90047-2"},{"key":"S0033291700018870_ref140","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1971.01750140042008"},{"key":"S0033291700018870_ref139","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.130.6.695"},{"key":"S0033291700018870_ref138","doi-asserted-by":"publisher","DOI":"10.1007\/BF00421010"},{"key":"S0033291700018870_ref137","first-page":"297","volume-title":"Monoamine Oxidase and Its Inhibition","author":"Roth","year":"1976"},{"key":"S0033291700018870_ref136","first-page":"167","volume-title":"Genetics, Environment and Psychopathology","author":"Rosenthal","year":"1974"},{"key":"S0033291700018870_ref134","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1973.04200030093015"},{"key":"S0033291700018870_ref133","unstructured":"Robinson D. S. & Nies A. (1975). The efficacy of the monoamine oxidase inhibitor, phenelzine.Neuropsychopharmacology, Proceedings of the IX Congress of the Collegium Internationale Neuropsychopharmacologicum (ed. Boissier J. R. , Hippius H. , and Pichot P. ), pp. 57\u201364. Elsevier: Amsterdam."},{"key":"S0033291700018870_ref131","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1176\/ajp.133.6.646","article-title":"Clinical response and plasma levels: effects of dose, dosage schedules, and drug interactions of plasma chlorpromazine levels","volume":"133","author":"Rivera-Calimlim","year":"1976","journal-title":"American Journal of Psychiatry"},{"key":"S0033291700018870_ref130","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1973146978"},{"key":"S0033291700018870_ref129","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.131.1.25"},{"key":"S0033291700018870_ref132","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.110.466.419"},{"key":"S0033291700018870_ref128","first-page":"30","article-title":"Drug treatment in depressive illness","volume":"31","author":"Rickels","year":"1970","journal-title":"Diseases of the Nervous System"},{"key":"S0033291700018870_ref127","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-196403000-00013"},{"key":"S0033291700018870_ref126","volume-title":"Non-Specific Factors in Drug Therapy","author":"Rickels","year":"1968"},{"key":"S0033291700018870_ref125","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-349-03753-7_3"},{"key":"S0033291700018870_ref124","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1974.01760070050008"},{"key":"S0033291700018870_ref123","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1970.01750020068009"},{"key":"S0033291700018870_ref122","first-page":"2","article-title":"Evidence indicating an association between schizophrenia and dopaminergic hyperactivity in the brain","volume":"1","author":"Randrup","year":"1972","journal-title":"Orthomolecular Psychiatry"},{"key":"S0033291700018870_ref119","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.131.2.198"},{"key":"S0033291700018870_ref118","doi-asserted-by":"publisher","DOI":"10.1002\/cpt196564430"},{"key":"S0033291700018870_ref117","first-page":"1","article-title":"A survey of bipolar and unipolar recurrent depressive psychoses","volume":"42","author":"Perris","year":"1966","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"S0033291700018870_ref151","doi-asserted-by":"publisher","DOI":"10.1126\/science.184.4143.1243"},{"key":"S0033291700018870_ref116","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)90284-5"},{"key":"S0033291700018870_ref115","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.120.555.147"},{"key":"S0033291700018870_ref114","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.118.544.275"},{"key":"S0033291700018870_ref113","doi-asserted-by":"publisher","DOI":"10.1007\/BF00279212"},{"key":"S0033291700018870_ref109","unstructured":"Murphy D. L. , Slater S. , de la Vega E. , Lipper S. & Costa J. L. (1978). A preliminary evaluation of the effects of fenfluramine in bipolar and unipolar depressed patients. Psychopharmacology Communications (in the press)."},{"key":"S0033291700018870_ref106","doi-asserted-by":"publisher","DOI":"10.1038\/229135a0"},{"key":"S0033291700018870_ref105","first-page":"277","volume-title":"The Biology of the Major Psychoses: a Comparative Analysis","author":"Murphy","year":"1975"},{"key":"S0033291700018870_ref102","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1974.01760170043007"},{"key":"S0033291700018870_ref101","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-3589(08)60185-4"},{"key":"S0033291700018870_ref100","unstructured":"Murphy D. L. (1972). Neurotransmitters. Research Publications, Association for Research in Nervous and Mental Disorders, No. 50, pp. 472\u2013493."},{"key":"S0033291700018870_ref097","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(69)92550-1"},{"key":"S0033291700018870_ref096","volume-title":"The Vital Balance: the Life Process in Mental Health and Illness","author":"Menninger","year":"1963"},{"key":"S0033291700018870_ref095","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1975.01760190024002"},{"key":"S0033291700018870_ref092","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1176\/ajp.133.4.373","article-title":"Lithium in the treatment of depression","volume":"133","author":"Mendels","year":"1976","journal-title":"American Journal of Psychiatry"},{"key":"S0033291700018870_ref091","volume-title":"Lithium Research and Therapy","author":"Mendels","year":"1975"},{"key":"S0033291700018870_ref090","volume-title":"Genetic Research in Psychiatry","author":"Mendelewiez","year":"1975"},{"key":"S0033291700018870_ref089","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.130.9.1011"},{"key":"S0033291700018870_ref088","first-page":"573","article-title":"Modified amine hypothesis for the aetiology of affective illness","volume":"ii","year":"1972","journal-title":"Lancet"},{"key":"S0033291700018870_ref111","first-page":"369","article-title":"Difference in clinical effects of three phenothiazines in \u2018acute\u2019 schizophrenia","volume":"28","year":"1967","journal-title":"Diseases of the Nervous System"},{"key":"S0033291700018870_ref067","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.126.2.160"},{"key":"S0033291700018870_ref094","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750200058012"},{"key":"S0033291700018870_ref082","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750210060012"},{"key":"S0033291700018870_ref161","doi-asserted-by":"publisher","DOI":"10.1007\/BF00428897"},{"key":"S0033291700018870_ref047","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1967.01730190109015"},{"key":"S0033291700018870_ref062","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-440X(68)80053-7"},{"key":"S0033291700018870_ref029","unstructured":"Donnelly E. F. , Murphy D. L. , Waldman I. N. & Goodwin F. K. (1978). Prediction of antidepressant responses to lithium. American Journal of Psychiatry (in the press)."},{"key":"S0033291700018870_ref040","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197503062921001"},{"key":"S0033291700018870_ref155","first-page":"1","volume-title":"Psychiatric Diagnosis","author":"Spitzer","year":"1977"},{"key":"S0033291700018870_ref005","doi-asserted-by":"publisher","DOI":"10.1007\/BF00407438"},{"key":"S0033291700018870_ref022","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750270014002"},{"key":"S0033291700018870_ref006","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5770.331"},{"key":"S0033291700018870_ref066","first-page":"1186","article-title":"Behaviour responses to drugs and brain catecholeamine levels in mice","volume":"26","author":"Karczmar","year":"1967","journal-title":"Federation Proceedings: Federation of American Societies for Experimental Biology"},{"key":"S0033291700018870_ref164","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1176\/ajp.133.10.1171","article-title":"Importance of dopamine metabolism for the clinical effects and side effects of neuroleptics","volume":"133","author":"van Praag","year":"1976","journal-title":"American Journal of Psychiatry"},{"key":"S0033291700018870_ref154","volume-title":"Biometrics Research","author":"Spitzer","year":"1975"},{"key":"S0033291700018870_ref011","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1975.01760190019001"},{"key":"S0033291700018870_ref053","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.130.1.73"},{"key":"S0033291700018870_ref061","volume-title":"Lithium Research and Therapy","author":"Johnson","year":"1975"},{"key":"S0033291700018870_ref171","volume-title":"Prediction of Response to Pharmacotherapy","author":"Wittenborn","year":"1966"},{"key":"S0033291700018870_ref030","first-page":"353","article-title":"Phenelzine, mood response and sleep","volume":"28","author":"Dunleavy","year":"1973","journal-title":"British Journal of Psychiatry"},{"key":"S0033291700018870_ref036","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1971.01750150055008"},{"key":"S0033291700018870_ref071","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1967.01730190120016"},{"key":"S0033291700018870_ref108","doi-asserted-by":"publisher","DOI":"10.1007\/BF00421216"},{"key":"S0033291700018870_ref072","doi-asserted-by":"publisher","DOI":"10.1007\/BF00404952"},{"key":"S0033291700018870_ref146","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-08-020928-9.50007-4"},{"key":"S0033291700018870_ref110","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700013805"},{"key":"S0033291700018870_ref135","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700018304"},{"key":"S0033291700018870_ref098","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1977.tb00138.x"},{"key":"S0033291700018870_ref083","first-page":"1139","volume-title":"Psychopharmacology: a Generation of Progress","author":"May","year":"1977"},{"key":"S0033291700018870_ref159","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700046419"},{"key":"S0033291700018870_ref085","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-197603000-00004"},{"key":"S0033291700018870_ref002","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1974.01760090038006"},{"key":"S0033291700018870_ref148","volume-title":"Presented at the American Psychopathological Association","author":"Singer","year":"1977"},{"key":"S0033291700018870_ref073","volume-title":"Diagnosis and Drug Treatment of Psychiatric Disorders","author":"Klein","year":"1969"},{"key":"S0033291700018870_ref063","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.119.550.267"},{"key":"S0033291700018870_ref031","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.129.1.40"},{"key":"S0033291700018870_ref017","volume-title":"Presented at the July Quarterly Meeting of the Royal College of Psychiatrists","author":"Brockington","year":"1976"},{"key":"S0033291700018870_ref064","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)90715-0"},{"key":"S0033291700018870_ref121","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-349-03753-7"},{"key":"S0033291700018870_ref004","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5686.764"},{"key":"S0033291700018870_ref045","first-page":"153","article-title":"Schizophrenic subtypes defined by response to drugs and placebo","volume":"29","author":"Goldberg","year":"1968","journal-title":"Diseases of the Nervous System"},{"key":"S0033291700018870_ref021","unstructured":"Bunney W. E. Jr , Brodie H. K. H. , Murphy D. L. & Goodwin F. K. (1970). Psychopharmacological differentiation between two subgroups of depressed patients.Proceedings of the American Psychological Association."},{"key":"S0033291700018870_ref008","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.127.6.759"},{"key":"S0033291700018870_ref010","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.119.3.210"},{"key":"S0033291700018870_ref173","volume-title":"Psychopharmacology and the Individual Patient","author":"Wittenborn","year":"1968"},{"key":"S0033291700018870_ref038","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750190059011"},{"key":"S0033291700018870_ref048","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750220077015"},{"key":"S0033291700018870_ref103","volume-title":"Current Issues in Psychiatric Diagnosis","author":"Murphy","year":"1978"},{"key":"S0033291700018870_ref093","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(73)90005-8"},{"key":"S0033291700018870_ref018","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(72)92533-0"},{"key":"S0033291700018870_ref025","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1976.tb00654.x"},{"key":"S0033291700018870_ref032","volume-title":"Drug Resistance and Selectivity","author":"Elliott","year":"1973"},{"key":"S0033291700018870_ref057","volume-title":"Clinical Use of Psychotherapeutic Drugs","author":"Hollister","year":"1973"},{"key":"S0033291700018870_ref023","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770090041003"},{"key":"S0033291700018870_ref157","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1975.01760250055005"},{"key":"S0033291700018870_ref112","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1966.03100110114031"},{"key":"S0033291700018870_ref026","volume-title":"Psychiatric Diagnosis in New York and London","author":"Cooper","year":"1972"},{"key":"S0033291700018870_ref079","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.107.450.876"},{"key":"S0033291700018870_ref044","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1176\/ajp.132.7.716","article-title":"Depression, delusions and drug response","volume":"132","author":"Glassman","year":"1975","journal-title":"American Journal of Psychiatry"},{"key":"S0033291700018870_ref050","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/1.3.24"},{"key":"S0033291700018870_ref041","first-page":"249","volume-title":"Neuropsychopharmacology","volume":"4","author":"Freyhan","year":"1965"},{"key":"S0033291700018870_ref080","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1176\/ajp.134.6.631","article-title":"Trends in the frequency of schizophrenia by different diagnostic criteria","volume":"134","author":"Kuriansky","year":"1977","journal-title":"American Journal of Psychiatry"},{"key":"S0033291700018870_ref054","volume-title":"Pharmacokinetics of Psychoactive Drugs","author":"Gottschalk","year":"1976"},{"key":"S0033291700018870_ref167","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1971.tb46950.x"},{"key":"S0033291700018870_ref019","first-page":"19","article-title":"Average evoked response in affective disorders","volume":"128","author":"Buchsbaum","year":"1971","journal-title":"American Journal of Psychiatry"},{"key":"S0033291700018870_ref120","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770100029002"},{"key":"S0033291700018870_ref087","first-page":"881","article-title":"Clinical trial of the treatment of depressive illness","volume":"i","year":"1965","journal-title":"British Medical Journal"},{"key":"S0033291700018870_ref150","volume-title":"Variability in Human Drug Response","author":"Smith","year":"1973"},{"key":"S0033291700018870_ref007","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1973142277"},{"key":"S0033291700018870_ref074","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-197303000-00003"},{"key":"S0033291700018870_ref104","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.128.11.1351"},{"key":"S0033291700018870_ref141","first-page":"199","volume-title":"Pharmacokinetics of Psychoactive Drugs","author":"Schooler","year":"1976"},{"key":"S0033291700018870_ref058","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1974.01760070072011"},{"key":"S0033291700018870_ref001","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1176\/ajp.1974.131.4.448","article-title":"High frequency of dysphoric reactions to tetrahydrocannabinol among depressed patients","volume":"131","author":"Ablon","year":"1974","journal-title":"American Journal of Psychiatry"},{"key":"S0033291700018870_ref003","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)91359-7"},{"key":"S0033291700018870_ref009","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.107.448.538"},{"key":"S0033291700018870_ref012","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.128.6.688"},{"key":"S0033291700018870_ref168","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-349-03753-7_6"},{"key":"S0033291700018870_ref013","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770120083009"},{"key":"S0033291700018870_ref014","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.129.6.513"},{"key":"S0033291700018870_ref015","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.129.6.574"},{"key":"S0033291700018870_ref020","volume-title":"Pre- and Post-Synaptic Receptors","author":"Bunney","year":"1975"},{"key":"S0033291700018870_ref024","first-page":"74","article-title":"Improving psychiatric drug therapy","volume":"29","author":"Cole","year":"1974","journal-title":"Geriatrics"},{"key":"S0033291700018870_ref028","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(61)92186-9"},{"key":"S0033291700018870_ref099","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.131.5.486"},{"key":"S0033291700018870_ref033","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.119.551.399"},{"key":"S0033291700018870_ref065","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1977.01770150104012"},{"key":"S0033291700018870_ref035","first-page":"295","article-title":"L-Tryptophan in depression","volume":"11","author":"Farkas","year":"1976","journal-title":"Biological Psychiatry"},{"key":"S0033291700018870_ref037","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750210054011"},{"key":"S0033291700018870_ref042","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-196808000-00009"},{"key":"S0033291700018870_ref039","volume-title":"EEG response strategies in psychiatric diagnosis","author":"Fink","year":"1977"},{"key":"S0033291700018870_ref043","first-page":"85","volume-title":"Biology of the Major Psychoses","author":"Gershon","year":"1975"},{"key":"S0033291700018870_ref046","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.111.471.120"},{"key":"S0033291700018870_ref049","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1977.01770140061008"},{"key":"S0033291700018870_ref086","first-page":"502","article-title":"Strain differences in the facilitative effects of 1757 I.S. on maze learning","volume":"54","author":"McGauch","year":"1961","journal-title":"Journal of Comparative and Physiological Psychology"},{"key":"S0033291700018870_ref051","first-page":"341","article-title":"L-Dopa, catecholamines and behaviour: a clincial and biochemical study in depressed patients","volume":"2","author":"Goodwin","year":"1970","journal-title":"Biological Psychiatry"},{"key":"S0033291700018870_ref052","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.129.1.44"},{"key":"S0033291700018870_ref055","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1975.01760210109008"},{"key":"S0033291700018870_ref016","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)92178-X"},{"key":"S0033291700018870_ref056","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1977.01770140019001"},{"key":"S0033291700018870_ref149","doi-asserted-by":"publisher","DOI":"10.1159\/000468267"},{"key":"S0033291700018870_ref107","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.130.1.79"},{"key":"S0033291700018870_ref059","volume-title":"Depressive States: A Pharmacotherapeutic Study","author":"Hordern","year":"1965"},{"key":"S0033291700018870_ref060","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1176\/ajp.132.6.644","article-title":"MMPI delineation of a subgroup of depressed patients refractory to lithium carbonate therapy","volume":"132","author":"House","year":"1975","journal-title":"American Journal of Psychiatry"},{"key":"S0033291700018870_ref027","volume-title":"Current Issues in Psychiatric Diagnosis","author":"Cowdry","year":"1978"},{"key":"S0033291700018870_ref068","volume-title":"The Role of Diagnosis in Psychiatry","author":"Kendell","year":"1975"},{"key":"S0033291700018870_ref069","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1192\/S0007125000012010","article-title":"Imipramine and depression","volume":"130","author":"Kerry","year":"1977","journal-title":"British Journal of Psychiatry"},{"key":"S0033291700018870_ref070","doi-asserted-by":"publisher","DOI":"10.1007\/BF02193476"},{"key":"S0033291700018870_ref075","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1977.01770210125012"},{"key":"S0033291700018870_ref076","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197509252931307"},{"key":"S0033291700018870_ref077","doi-asserted-by":"publisher","DOI":"10.1007\/BF00453508"},{"key":"S0033291700018870_ref034","volume-title":"The Biological Basis of Personality","author":"Eysenck","year":"1967"},{"key":"S0033291700018870_ref078","first-page":"445","article-title":"Plasma levels of nortriptyline in the treatment of endogenous depression","volume":"49","author":"Kragh-Sorenson","year":"1973","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"S0033291700018870_ref158","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.128.4.354"},{"key":"S0033291700018870_ref081","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5775.599"},{"key":"S0033291700018870_ref084","volume-title":"Psychotropic Drug Response","author":"May","year":"1969"}],"container-title":["Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0033291700018870","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T11:31:55Z","timestamp":1589974315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291700018870\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1978,11]]},"references-count":176,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1978,11]]}},"alternative-id":["S0033291700018870"],"URL":"https:\/\/doi.org\/10.1017\/s0033291700018870","relation":{},"ISSN":["0033-2917","1469-8978"],"issn-type":[{"value":"0033-2917","type":"print"},{"value":"1469-8978","type":"electronic"}],"subject":[],"published":{"date-parts":[[1978,11]]}}}